Published in J Biol Chem on March 15, 1993
Sulfur K-edge XAS and DFT calculations on P450 model complexes: effects of hydrogen bonding on electronic structure and redox potentials. J Am Chem Soc (2005) 1.01
Transition-state variation in human, bovine, and Plasmodium falciparum adenosine deaminases. J Am Chem Soc (2007) 0.98
Genetic and structural organization of the aminophenol catabolic operon and its implication for evolutionary process. J Bacteriol (2001) 0.97
The role of divalent cations in structure and function of murine adenosine deaminase. Protein Sci (1997) 0.88
A novel deaminase involved in chloronitrobenzene and nitrobenzene degradation with Comamonas sp. strain CNB-1. J Bacteriol (2007) 0.85
X-ray structure and mutational analysis of the atrazine Chlorohydrolase TrzN. J Biol Chem (2010) 0.82
The role of Zn2+ on the structure and stability of murine adenosine deaminase. J Phys Chem B (2010) 0.79
Nickel(II) complexes stabilized by bis[N-(6-pivalamido-2-pyridylmethyl)]benzylamine: Synthesis and characterization of complexes stabilized by a hydrogen bonding network. Inorganica Chim Acta (2010) 0.79
S K-edge XAS and DFT calculations on square-planar NiII-thiolate complexes: effects of active and passive H-bonding. Inorg Chem (2007) 0.77
Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci U S A (1993) 4.56
Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med (1984) 2.76
Identification and quantitation of adenine deoxynucleotides in erythrocytes of a patient with adenosine deaminase deficiency and severe combined immunodeficiency. J Biol Chem (1978) 2.56
Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease. J Clin Invest (1978) 2.07
Terminal deoxyribonucleotidyl transferase in human leukemia. Proc Natl Acad Sci U S A (1974) 1.72
A method for biotinylating oligonucleotide probes for use in molecular hybridizations. DNA (1986) 1.33
Terminal deoxynucleotidyl transferase and DNA polymerase in classes of cells from rat thymus. Biochem Biophys Res Commun (1974) 1.29
Serial observations on terminal deoxynucleotidyl transferase activity and lymphoblast surface markers in acute lymphoblastic leukemia. Cancer Res (1976) 1.26
Fast 2D phantom dosimetry for scanning proton beams. Med Phys (1998) 1.24
Terminal riboadenylate transferase in human lymphocytes. Nature (1974) 1.22
Xenopus peroxisome proliferator activated receptors: genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids. J Steroid Biochem Mol Biol (1993) 1.19
DNA polymerases in normal and leukemic human hematopoietic cells. Blood (1974) 1.18
In vivo absorbed dose measurements in mammography using a new real-time luminescence technique. Br J Radiol (2005) 1.17
Micromethod for quantitation of adenosine deaminase activity in cells from human peripheral blood. Biochem Med (1975) 1.16
Branched-chain amino-acid aminotransferase of Salmonella typhimurium. I. Crystallization and preliminary characterization. Biochim Biophys Acta (1971) 1.11
Peroxisome proliferator-activated receptors and lipid metabolism. Ann N Y Acad Sci (1993) 1.10
The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer. Phys Med Biol (2005) 1.07
The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancy. Blood (1981) 1.06
ATP depletion as a consequence of adenosine deaminase inhibition in man. Proc Natl Acad Sci U S A (1980) 1.04
Purification, characterization and radioimmunoassay of adenosine deaminase from human leukaemic granulocytes. Biochem J (1981) 1.01
Inhibition of T lymphocyte activation in mice heterozygous for loss of the IMPDH II gene. J Clin Invest (2000) 1.01
Adenosine deaminase activity in peripheral blood cells of patients with haematological malignancies. Br J Cancer (1976) 0.99
Purification of a high molecular weight human terminal deoxynucleotidyl transferase. J Biol Chem (1979) 0.98
Human terminal deoxyribonucleotidyltransferase: molecular cloning and structural analysis of the gene and 5' flanking region. Proc Natl Acad Sci U S A (1988) 0.97
Terminal deoxynucleotidyl transferase measurements in the differential diagnosis of adult leukaemias. Br J Haematol (1976) 0.97
Terminal deoxynucleotidyl transferase: characterization of extraction and assay conditions from human and calf tissue. Arch Biochem Biophys (1977) 0.95
Mutational analysis of residues in the nucleotide binding domain of human terminal deoxynucleotidyl transferase. J Biol Chem (1994) 0.94
Biochemical properties of purified human terminal deoxynucleotidyltransferase. J Biol Chem (1980) 0.94
Terminal deoxynucleotidyltransferase distribution in neoplastic and hematopoietic cells. J Clin Invest (1977) 0.93
Efficient, low-cost protein factories: expression of human adenosine deaminase in baculovirus-infected insect larvae. Proc Natl Acad Sci U S A (1990) 0.93
A critical comparison of commonly used procedures for the assay of terminal deoxynucleotidyl transferase in crude tissue extracts. Nucleic Acids Res (1977) 0.92
Identification of a tripartite basal promoter which regulates human terminal deoxynucleotidyl transferase gene expression. J Biol Chem (1994) 0.92
Proton dosimetry intercomparison. Radiother Oncol (1996) 0.92
General characteristics of the use of silicon diode detectors for clinical dosimetry in proton beams. Phys Med Biol (2000) 0.91
Terminal deoxynucleotidyltransferase. Alignment of alpha- and beta-subunits of the core enzyme along the primary translation product. Biochem J (1985) 0.91
Biochemical and functional abnormalities in lymphocytes from an adenosine deaminase-deficient patient during enzyme replacement therapy. J Clin Invest (1981) 0.91
Constraints of the multiple-scattering theory of Molière in Monte Carlo simulations of the transport of charged particles. Med Phys (1994) 0.91
Adenosine deaminase, terminal deoxynucleotidyl transferase (TdT), and cell surface markers in childhood acute leukemia. Blood (1978) 0.91
Interactions of photoactive DNAs with terminal deoxynucleotidyl transferase: identification of peptides in the DNA binding domain. Biochemistry (1991) 0.90
Time-resolved fluorescence spectroscopy of human adenosine deaminase: effects of enzyme inhibitors on protein conformation. Biochemistry (1989) 0.89
Terminal deoxynucleotidyl transferase and adenosine deaminase in human lymphoblastoid cell lines. Exp Cell Res (1975) 0.89
Expression of terminal deoxynucleotidyl transferase in human thymus during ontogeny and development. J Immunol (1983) 0.88
Immunological and biochemical profiles in response to transfusion therapy in an adenosine deaminase-deficient patient with severe combined immunodeficiency disease. Clin Immunol Immunopathol (1979) 0.88
Initiation of transcription at the human terminal deoxynucleotidyl transferase gene promoter: a novel role for the TATA binding protein. Biochemistry (1994) 0.88
An algorithm for real-time dosimetry in intensity-modulated radiation therapy using the radioluminescence signal from Al2O3:C. Radiat Prot Dosimetry (2006) 0.87
Photoaffinity labeling of terminal deoxynucleotidyl transferase. 2. Identification of peptides in the nucleotide binding domain. Biochemistry (1989) 0.87
Initiator role of double stranded DNA in terminal transferase catalyzed polymerization reactions. Nucleic Acids Res (1988) 0.86
Limited proteolysis of calf thymus terminal deoxynucleotidyl transferase. Arch Biochem Biophys (1980) 0.86
Deoxynucleotide-interconverting enzymes and the quantification of deoxynucleoside triphosphates in mammalian cells. Biochem J (1982) 0.85
Expression of foreign proteins in Trichoplusia ni larvae. Methods Mol Biol (1995) 0.84
Comparison of the native prothrombin antigen and the prothrombin time for monitoring oral anticoagulant therapy. Blood (1984) 0.84
Branched chain amino acid aminotransferase of Salmonella typhimurium. II. Kinetic comparison with the enzyme from Salmonella montevideo. J Biol Chem (1971) 0.83
Can the average glandular dose in routine digital mammography screening be reduced? A pilot study using revised image quality criteria. Radiat Prot Dosimetry (2005) 0.82
Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosine. J Immunol (1983) 0.82
Nanodosimetry in a clinical neutron therapy beam using the variance-covariance method and Monte Carlo simulations. Phys Med Biol (2007) 0.82
Isolation of mutant adenosine deaminase by coformycin affinity chromatography. Anal Biochem (1986) 0.81
Reappearance of terminal deoxynucleotidyl transferase containing cells in rat bone marrow following corticosteroid administration. Blood (1980) 0.81
Ferrous sulphate gel dosimetry and MRI for proton beam dose measurements. Phys Med Biol (1999) 0.81
Philadelphia-chromosome-positive pre-B-cell leukemia presenting as blast crisis of chronic myelogenous leukemia. Blood (1979) 0.81
Immunoaffinity purification and fluorescence studies of human adenosine deaminase. Biochemistry (1987) 0.80
Induction of spleen cell growth and DNA polymerase activity by Corynebacterium parvum. Cancer Res (1978) 0.80
Interaction of terminal transferase with single-stranded DNA. J Biol Chem (1987) 0.80
Unusual immunofluorescence patterns for terminal deoxynucleotidyl transferase in blast crisis chronic myelogenous leukemia. Am J Clin Pathol (1981) 0.80
In vitro metabolism of deoxycoformycin in human T lymphoblastoid cells. Phosphorylation of deoxycoformycin and incorporation into cellular DNA. J Biol Chem (1984) 0.79
Affinity purification and refined structural characterization of terminal deoxynucleotidyltransferase. Biochem J (1985) 0.79
Biochemical and immunological properties of human terminal deoxynucleotidyl transferase purified from blasts of acute lymphoblastic and chronic myelogenous leukemia. J Clin Invest (1981) 0.79
Clinical evaluation of a new set of image quality criteria for mammography. Radiat Prot Dosimetry (2005) 0.78
Characterization of purine nucleoside phosphorylase from human granulocytes and its metabolism of deoxyribonucleosides. J Biol Chem (1980) 0.78
Adenosine deaminase and terminal deoxynucleotidyl transferase: biochemical markers in the management of chronic myelogenous leukemia. Cancer Res (1983) 0.78
A new solid-phase immunoassay for terminal deoxynucleotidyl transferase: analysis of TdT antigen in cells, plasma, and serum. Blood (1985) 0.78
Molecular cloning of the UMP synthase gene rudimentary-like from Drosophila melanogaster. Mol Gen Genet (1990) 0.78
Aspartate transcarbamylases of Citrobacter freundii. Biochemistry (1971) 0.78
T-cell specific avian TdT: characterization of the cDNA and recombinant enzyme. Nucleic Acids Res (1995) 0.78
Photoaffinity labeling of terminal deoxynucleotidyl transferase. 1. Active site directed interactions with 8-azido-2'-deoxyadenosine 5'-triphosphate. Biochemistry (1989) 0.78
A Monte Carlo study of the energy dependence of Al2O3:C crystals for real-time in vivo dosimetry in mammography. Radiat Prot Dosimetry (2005) 0.78
Tissue-specific expression of human terminal deoxynucleotidyl transferase is regulated at the transcriptional level. Biochem Biophys Res Commun (1989) 0.77
Evaluation of methods of detecting terminal deoxynucleotidyl transferase in human hematologic malignancies. Comparison of immunofluorescence and enzymatic assays. Am J Clin Pathol (1982) 0.77
Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis. Cancer Res (1980) 0.77
Adenosine deaminase and immune dysfunction. Biochemical correlates defined by molecular analysis throughout a disease course. Ann N Y Acad Sci (1985) 0.76
2'-deoxycoformycin (DCF) and 9-beta-D-arabinofuranosyladenine (Ara-A) in the treatment of refractory acute myelocytic leukemia. Cancer Treat Rep (1982) 0.76
On the calibration of plane-parallel ion chambers using 60Co beams. Med Phys (1991) 0.75
Exploiting biochemical differences in leukemia. Adv Exp Med Biol (1984) 0.75
Street runoff as a source of lead pollution. J Water Pollut Control Fed (1974) 0.75
Evaluation of a new enzyme-linked immunoassay for terminal deoxynucleotidyl transferase in haematologic malignancies. Br J Haematol (1986) 0.75
Videoconferencing and coronary angiography. J Telemed Telecare (1996) 0.75
Clinical utility of initial terminal deoxynucleotidyl transferase determinations in childhood acute leukemias. Cancer Res (1981) 0.75
Terminal deoxynucleotidyl transferase activity in thymocytes of kittens. Am J Vet Res (1985) 0.75
The origin of multiple forms of human and calf terminal deoxynucleotidyl transferase: a model for in vivo processing. Isozymes Curr Top Biol Med Res (1983) 0.75
Effects of antineoplastic and immunosuppressant drugs on deoxyribonucleic acid-polymerizing enzymes of rat thymus and spleen. Mol Pharmacol (1977) 0.75
Development of a compact proton scanning system in Uppsala with a moveable second magnet. Phys Med Biol (2000) 0.75
Response of lympho-hemopoietic tissue to Corynebacterium parvum by study of DNA enzymes and H3-TdR metabolism. Cancer Biochem Biophys (1979) 0.75
Incorporation of uridine into polysomes of mouse brain during extinction. Nature (1971) 0.75
EMT6 solid tumor growth, DNA synthesis and DNA polymerase activity. Cancer Biochem Biophys (1980) 0.75
Brain function and macromolecules. 8. Uridine incorporation into brain polysomes of hypophysectomized rats and ovariectomized mice during avoidance conditioning. Brain Res (1971) 0.75
Supplemental feeding of marmoset (Callithrix jacchus) triplets. Lab Anim Sci (1981) 0.75
Teleradiology by two different concepts. Technical note. Acta Radiol (1997) 0.75
Lack of functional significance of Cys227 and Cys234 in terminal deoxynucleotidyltransferase. J Biol Chem (1992) 0.75
Detection of mRNA for adenosine deaminase using biotinylated probes. Adv Exp Med Biol (1986) 0.75